Opiant Pharmaceuticals to Report Second Quarter 2020 Financial Results and Host Conference Call and Webcast on August 6, 2020

Rhea-AI Summary

Opiant Pharmaceuticals (NASDAQ: OPNT) will release its second quarter 2020 financial results on August 6, 2020, after market close. A conference call and webcast hosted by the management team will follow at 4:30 p.m. ET. Interested parties can join the call by dialing 877-407-0792 for domestic calls or 201-689-8263 for international callers, using the conference ID 13706176. Opiant is known for developing medicines for addictions and drug overdose, including the NARCAN® Nasal Spray.

SANTA MONICA, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced it will report its second quarter 2020 financial results after the financial markets close on Thursday August 6, 2020.  

The Company’s management team is scheduled to host a conference call and webcast at 4:30 p.m. ET on Thursday August 6, 2020. To access the call, please dial 877-407-0792 in the U.S. or 201-689-8263 outside the U.S. and provide the conference ID number: 13706176. To access the live webcast, please go to the investors section of Opiant’s website at http://ir.opiant.com/. Following the live webcast, an archived version of the call will be available on the website.

100%; border-collapse:collapse !important;">

Thursday August 6 @ 4:30 pm ET
8%; width:8%; min-width:8%;">Domestic:	92%; width:92%; min-width:92%;">877-407-0792
International:	201-689-8263
Conference ID:	13706176
Webcast:	http://ir.opiant.com/

About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose.
For more information visit: www.opiant.com.

Investor Relations Contacts:
Ben Atkins
VP of Corporate Communications and Investor Relations
batkins@opiant.com
(310) 589-5410

Dan Ferry
Managing Director
LifeSci Advisors, LLC
daniel@lifesciadvisors.com
(617) 430-7576

FAQ

When will Opiant Pharmaceuticals report its second quarter 2020 financial results?

Opiant Pharmaceuticals will report its second quarter 2020 financial results on August 6, 2020, after market close.

What time is the Opiant Pharmaceuticals conference call on August 6, 2020?

The conference call will take place at 4:30 p.m. ET on August 6, 2020.

How can I access the Opiant Pharmaceuticals conference call?

The conference call can be accessed by dialing 877-407-0792 in the U.S. or 201-689-8263 internationally, using the conference ID 13706176.

Where can I find the webcast for Opiant Pharmaceuticals' conference call?

The webcast will be available on Opiant's investor relations website at http://ir.opiant.com.